학술논문
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
Document Type
Artikel
Author
Source
Arthritis and rheumatism. 63(12):3918-3930
Subject
Language
English
English
English
ISSN
1529-0131